BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25278684)

  • 1. Potential role of metabolomics in diagnosis and surveillance of gastric cancer.
    Chan AW; Gill RS; Schiller D; Sawyer MB
    World J Gastroenterol; 2014 Sep; 20(36):12874-82. PubMed ID: 25278684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric cancer: Metabolic and metabolomics perspectives (Review).
    Xiao S; Zhou L
    Int J Oncol; 2017 Jul; 51(1):5-17. PubMed ID: 28535006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic studies of human gastric cancer: review.
    Jayavelu ND; Bar NS
    World J Gastroenterol; 2014 Jul; 20(25):8092-101. PubMed ID: 25009381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of metabolomic profiling of gastric cancer and esophageal cancer.
    Huang S; Guo Y; Li Z; Zhang Y; Zhou T; You W; Pan K; Li W
    Cancer Biol Med; 2020 Feb; 17(1):181-198. PubMed ID: 32296585
    [No Abstract]   [Full Text] [Related]  

  • 5. Glucose metabolism in gastric cancer: The cutting-edge.
    Yuan LW; Yamashita H; Seto Y
    World J Gastroenterol; 2016 Feb; 22(6):2046-59. PubMed ID: 26877609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomic profiling of oesophago-gastric cancer: a systematic review.
    Abbassi-Ghadi N; Kumar S; Huang J; Goldin R; Takats Z; Hanna GB
    Eur J Cancer; 2013 Nov; 49(17):3625-37. PubMed ID: 23896378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR.
    Wang H; Zhang H; Deng P; Liu C; Li D; Jie H; Zhang H; Zhou Z; Zhao YL
    BMC Cancer; 2016 Jun; 16():371. PubMed ID: 27356757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying the Metabolic Signatures of PPARD-Overexpressing Gastric Tumors.
    Pudakalakatti S; Titus M; Enriquez JS; Ramachandran S; Zacharias NM; Shureiqi I; Liu Y; Yao JC; Zuo X; Bhattacharya PK
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating metabolites as potential biomarkers for the early detection and prognosis surveillance of gastrointestinal cancers.
    Song G; Wang L; Tang J; Li H; Pang S; Li Y; Liu L; Hu J
    Metabolomics; 2023 Apr; 19(4):36. PubMed ID: 37014438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative proteomic analysis reveals that proteins required for fatty acid metabolism may serve as diagnostic markers for gastric cancer.
    Jiang Z; Shen H; Tang B; Yu Q; Ji X; Wang L
    Clin Chim Acta; 2017 Jan; 464():148-154. PubMed ID: 27884752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear magnetic resonance-based tissue metabolomic analysis clarifies molecular mechanisms of gastric carcinogenesis.
    Gu J; Huang C; Hu X; Xia J; Shao W; Lin D
    Cancer Sci; 2020 Sep; 111(9):3195-3209. PubMed ID: 32369664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
    Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
    Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminating gastric cancer and gastric ulcer using human plasma amino acid metabolic profile.
    Jing F; Hu X; Cao Y; Xu M; Wang Y; Jing Y; Hu X; Gao Y; Zhu Z
    IUBMB Life; 2018 Jun; 70(6):553-562. PubMed ID: 29626382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
    Liang Q; Wang C; Li B
    Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive diagnosis and evaluation of curative surgery for gastric cancer by using NMR-based metabolomic profiling.
    Jung J; Jung Y; Bang EJ; Cho SI; Jang YJ; Kwak JM; Ryu DH; Park S; Hwang GS
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S736-42. PubMed ID: 25092158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a mass spectrometry-based pseudotargeted metabolomics strategy to analyze hormone-stimulated gastric cancer cells.
    Li J; Wang Q; Zheng Y; Zhou P; Xu X; Liu X; Zhao L; Liu H
    J Pharm Biomed Anal; 2020 Feb; 180():113041. PubMed ID: 31855724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry.
    Wu H; Xue R; Tang Z; Deng C; Liu T; Zeng H; Sun Y; Shen X
    Anal Bioanal Chem; 2010 Feb; 396(4):1385-95. PubMed ID: 20012946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics of gastric cancer metastasis detected by gas chromatography and mass spectrometry.
    Chen JL; Tang HQ; Hu JD; Fan J; Hong J; Gu JZ
    World J Gastroenterol; 2010 Dec; 16(46):5874-80. PubMed ID: 21155010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancer.
    Meller S; Meyer HA; Bethan B; Dietrich D; Maldonado SG; Lein M; Montani M; Reszka R; Schatz P; Peter E; Stephan C; Jung K; Kamlage B; Kristiansen G
    Oncotarget; 2016 Jan; 7(2):1421-38. PubMed ID: 26623558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum metabolic profiling of human gastric cancer based on gas chromatography/mass spectrometry.
    Song H; Peng JS; Dong-Sheng Y; Yang ZL; Liu HL; Zeng YK; Shi XP; Lu BY
    Braz J Med Biol Res; 2012 Jan; 45(1):78-85. PubMed ID: 22124703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.